Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1527
2021 943
2022 302
2023 119
2024 68
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,592 results

Results by year

Filters applied: . Clear all
Page 1
Of chloroquine and COVID-19.
Touret F, de Lamballerie X. Touret F, et al. Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5. Antiviral Res. 2020. PMID: 32147496 Free PMC article. Review.
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider th …
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment …
Hydroxychloroquine and COVID-19.
Sinha N, Balayla G. Sinha N, et al. Postgrad Med J. 2020 Sep;96(1139):550-555. doi: 10.1136/postgradmedj-2020-137785. Epub 2020 Apr 15. Postgrad Med J. 2020. PMID: 32295814 Free PMC article. Review.
Hydroxychloroquine and chloroquine are medications that have been used for a long time. Their most common use is for the treatment and prophylaxis of malaria. ...Several in vitro studies have proven their effectiveness on severe acute respiratory syndrome virus and …
Hydroxychloroquine and chloroquine are medications that have been used for a long time. Their most common use is for the treat …
The race against COVID-19.
[No authors listed] [No authors listed] Nat Nanotechnol. 2020 Apr;15(4):239-240. doi: 10.1038/s41565-020-0680-y. Nat Nanotechnol. 2020. PMID: 32303704 No abstract available.
COVID-19 and Depression.
Shader RI. Shader RI. Clin Ther. 2020 Jun;42(6):962-963. doi: 10.1016/j.clinthera.2020.04.010. Epub 2020 Apr 27. Clin Ther. 2020. PMID: 32362345 Free PMC article.
The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. ...This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use …
The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. ...This commentary disc …
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. Boulware DR, et al. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492293 Free PMC article. Clinical Trial.
BACKGROUND: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ...CONCLUSIONS: After high-risk or moderate-risk exposure to …
BACKGROUND: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory …
Hydroxychloroquine and COVID-19: The endgame!
Deplanque D. Deplanque D. Therapie. 2023 Jul-Aug;78(4):343-344. doi: 10.1016/j.therap.2023.06.003. Epub 2023 Jun 7. Therapie. 2023. PMID: 37321943 Free PMC article. No abstract available.
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK, Mukaka M, Callery JJ, Llewelyn MJ, Cruz CV, Dhorda M, Ngernseng T, Waithira N, Ekkapongpisit M, Watson JA, Chandna A, Nelwan EJ, Hamers RL, Etyang A, Beg MA, Sow S, Yavo W, Allabi AC, Basnyat B, Sharma SK, Amofa-Sekyi M, Yonga P, Adler A, Yuentrakul P, Cope T, Thaipadungpanit J, Rienpradub P, Imwong M, Abdad MY, Blacksell SD, Tarning J, Goudjo FF, Dossou AD, Konaté-Touré A, Assi SB, Ouffoué K, Nasronudin N, Rachman BE, Romadhon PZ, Dewanto DD, Heryana MO, Novi T, Pasaribu AP, Mutiara M, Nasution MPR, Khairunnisa K, Dalimunthe FA, Airlangga E, Fahrezzy A, Subronto Y, Ananda NR, Rahardjani M, Rimainar A, Lucinde RK, Timbwa M, Onyango OE, Agutu C, Akech S, Hamaluba M, Kipyego J, Ngachi O, Haidara FC, Traoré OY, Diarra F, Khanal B, Dahal P, Shrestha S, Rijal S, Kabore Y, Adehossi E, Guindo O, Qamar FN, Kazi AM, Woodrow CJ, Laird S, Cheeba M, Ayles H, Cheah PY, Taylor WRJ, Batty EM, Chotivanich K, Pukrittayakamee S, Phumratanaprapin W, von Seidlein L, Dondorp A, Day NPJ, White NJ; COPCOV Collaborative Group. Schilling WHK, et al. PLoS Med. 2024 Sep 12;21(9):e1004428. doi: 10.1371/journal.pmed.1004428. eCollection 2024 Sep. PLoS Med. 2024. PMID: 39264960 Free PMC article. Clinical Trial.
The primary endpoint was symptomatic COVID-19, confirmed by PCR or seroconversion during the 3-month follow-up period. The secondary and tertiary endpoints were: asymptomatic laboratory-confirmed Severe Acute Respiratory Syndrome Coron …
The primary endpoint was symptomatic COVID-19, confirmed by PCR or seroconversion during the 3-month follow-up period. The sec …
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Yazdany J, Kim AHJ. Yazdany J, et al. Ann Intern Med. 2020 Jun 2;172(11):754-755. doi: 10.7326/M20-1334. Epub 2020 Mar 31. Ann Intern Med. 2020. PMID: 32232419 Free PMC article.
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019. The authors of this commentary provide guidance for cl …
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attr …
2,592 results